A Study to Assess Non-pharmaceutical Motion Sickness Mitigation

Overview

About this study

The purpose of this study is evaluate the effect of timing and magnitude on the administration of our nonpharmaceutical treatment to motion sickness, and to evaluate the effect of GVR amplitude on functional fitness task performance.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Must be able to consent to participate themselves.
Must be 21 to 55 years of age.
Must be able to attend in-person sessions at the Mayo Aerospace Medicine and Vestibular Research Laboratory in Scottsdale, AZ.
No racial ethnic groups will be excluded.
Must be fluent speakers of English.

Exclusion Criteria:

History of vestibular disease, migraine, or significant balance disorder.
Traumatic brain injury.
Recent middle ear infection or recent motion sickness (within 72 hours).
History of severe motion sensitivity.
Women who are pregnant.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Scottsdale/Phoenix, Ariz. Mayo Clinic principal investigator Gaurav Pradhan, Ph.D.	Closed for enrollment

Mayo Clinic Location

Status

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Gaurav Pradhan, Ph.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials